Metagenics is devoted to addressing the unmet needs of patients with chronic health conditions. Solutions to these conditions are not obvious, and often require innovative and integrated programs. Metagenics has many “Industry Firsts” in pioneering low toxicity, natural-based products to support a functional medicine, patient-centered program for conditions ranging from chronic fatigue and fibromyalgia to osteoarthritis and metabolic syndrome.
Metagenics has a history of leading the field of natural, science-based approaches to chronic health conditions. We are first in our market to:
Develop medical foods for hepatic detoxification and gastrointestinal disorders.
Discover and clinically test a natural, GI-friendly joint relief nutraceutical.
Research and identify low allergy potential rice protein to support the needs of food-sensitive patients.
Discern the relationship between methylation nutriture and estrogen metabolism, especially related to risk of hormone-dependent diseases.
Utilize nutrigenomics research for natural-based, targeted approaches to inflammation.
Commercialize a clinically researched medical food for insulin resistance/metabolic syndrome.
Recognize and bring to market Microcrystalline Hydroxyapatite Concentrate (MCHC) containing a full spectrum of bone support nutrients with bioactive protein.
Identify and commercialize a GI-friendly form of magnesium to support intestinal tolerance.
